MDLN (Medline Inc.) Stock Financials & Earnings | Market Cap Arena

MDLN (Medline Inc.) Stock Financials & Earnings | Market Cap Arena

MDLNMedline Inc.

Mkt Cap$35B

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Revenue (TTM)$28.4B

Net Income (TTM)$1.2B

EPS (TTM)$1.45

Free Cash Flow (TTM)$1.7B

Gross Margin24.6%

Op. Margin7.8%

Net Margin4.1%

FCF Margin6.1%

P/S Ratio (TTM)1.2x

P/E Ratio (TTM)30.5x

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q2 24	$6.2B	$1.5B	$516M
Q3 24	$6.4B	$1.6B	$574M
Q1 25	$6.6B	$1.6B	$591M
Q2 25	$6.9B	$1.7B	$629M
Q3 25	$7.1B	$1.7B	$574M
Q4 25	$7.8B	$1.9B	$425M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q2 24	—	—
Q3 24	—	—
Q1 25	—	—
Q2 25	1.4x	27.7x
Q3 25	1.3x	27.1x
Q4 25	1.2x	30.5x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 24	$722M	$615M
Q1 25	$636M	$535M
Q2 25	$243M	$103M
Q3 25	$636M	$535M
Q4 25	$229M	$571M

Capital Expenditures

CapEx

Quarter	CapEx
Q3 24	$107M
Q1 25	$101M
Q2 25	$140M
Q3 25	$101M
Q4 25	$342M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 25	+15.0%	+15.4%
Q4 25	+21.9%	+26.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 24	$0	0.0%
Q1 25	$0	0.0%
Q2 25	$0	0.0%
Q3 25	$0	0.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	SG&A
Q2 24	$976M
Q3 24	$988M
Q1 25	$1.1B
Q2 25	$1.1B
Q3 25	$1.1B
Q4 25	$1.3B

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 25	$0	$0	$0
Q2 25	$584M	$0	$584M
Q3 25	$955M	$0	$955M
Q4 25	$1.9B	$0	$1.9B

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q2 24	787M	—
Q3 24	787M	+0.0%
Q1 25	800M	+1.6%
Q2 25	787M	-1.6%
Q3 25	787M	+0.0%
Q4 25	812M	+3.2%